Scientific Opinion on the substantiation of health claims related to various food(s)/food constituents(s) and increasing numbers of gastro-intestinal microorganisms (ID 760, 761, 779, 780, 779, 1905), and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 760, 761, 779, 780, 779, 1905) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 8, Issue 10, 2010, Pages

[No Author Info available]

Author keywords

Gut microbiota; gut microflora; health claims; potentially pathogenic microorganisms

Indexed keywords

EID: 85074551673     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2010.1809     Document Type: Article

References (21)

1. Bertelsen H, Andersen H and Tvede M, 2001. Fermentation of D-Tagatose by Human Intestinal Bacteria and Dairy Lactic Acid Bacteria. Microbial Ecology in Health and Disease, 13, 87–95.
2. Bouhnik Y, Flourie B, Riottot M, Bisetti N, Gailing MF, Guibert A, Bornet F and Rambaud JC, 1996. Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans. Nutrition and Cancer, 26, 21–29.
3. Bouhnik Y, Raskine L, Simoneau G, Paineau D and Bornet F, 2006. The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans. Nutrition Journal, 5, 1–6.
4. Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, Marteau P, Flourie B, Bornet F and Rambaud JC, 1999. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. Journal of Nutrition, 129, 113–116.
5. Buddington RK, Williams CH, Chen SC and Witherly SA, 1996. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. American Journal of Clinical Nutrition, 63, 709–716.
6. Bunce TJ, Howard MD, Kerley MS, Allee GL and Pace LW 1995. Protective effect of fructooligosaccharides (FOS) in prevention of mortality and morbidity from infectious E.coli K:88 challenge. Journal of Animal Science, 73 (Suppl.1).
7. Cherbut C, Michel C and Lecannu G, 2003. The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. Journal of Nutrition, 133, 21–27.
8. Howard MD, Gordon DT, Pace LW, Garleb KA and Kerley MS, 1995. Effects of Dietary Supplementation with Fructooligosaccharides on Colonic Microbiota Populations and Epithelial-Cell Proliferation in Neonatal Pigs. Journal of Pediatric Gastroenterology and Nutrition, 21, 297–303.
9. Hsu CK, Liao JW, Chung YC, Hsieh CP and Chan YC, 2004. Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. Journal of Nutrition, 134, 1523–1528.
10. Kohmoto T, Fukui F, Takaku H and Mitsuoka T, 1991. Dose-response Test of Isomaltooligosaccharides for Increasing Fecal Bifidobacteria. Agricultural and Biological Chemistry, 55, 2157–2159.
11. Kohmoto T, Fukui F, Takaku H, Machida Y, Arai M and Mitsuoka T, 1988. Effect of isomalto-oligosaccharides on human fecal flora. Bifidobacteria and Microflora, 7, 61–69.
12. Le Blay G, Michel C, Blottiere HM and Cherbut C, 1999. Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in cecal butyrate in rats. Journal of Nutrition, 129, 2231–2235.
13. Mitsuoka T, Hidaka H and Eida T, 1987. Effect of fructo-oligosaccharides on intestinal microflora. Nahrung, 31, 427–436.
14. Perrin S, Warchol M, Grill JP and Schneider F, 2001. Fermentations of fructo-oligosaccharides and their components by Bifidobacterium infantis ATCC 15697 on batch culture in semi-synthetic medium. Journal of Applied Microbiology, 90, 859–865.
15. Rycroft CE, Jones MR, Gibson GR and Rastall RA, 2001. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. Journal of Applied Microbiology, 91, 878–887.
16. Sparkes AH, Papasouliotis K, Sunvold G, Werrett G, Gruffydd-Jones EA, Egan K, Gruffydd-Jones TJ and Reinhart G, 1998. Effect of dietarysupplementation with fructo-oligosaccharides on fecal flora of healthy cats. American Journal of Veterinary Research, 59, 436–440.
17. Swanson KS, Grieshop CM, Flickinger EA, Bauer LL, Chow JM, Wolf BW, Garleb KA and Fahey GC, 2002a. Fructooligosaccharides and Lactobacillus acidophilus modify gut microbial populations, total tract nutrient digestibilities and fecal protein catabolite concentrations in healthy adult dogs. Journal of Nutrition, 132, 3721–3731.
18. Swanson KS, Grieshop CM, Flickinger EA, Bauer LL, Healy HP, Dawson KA, Merchen NR and Fahey GC, 2002b. Supplemental fructooligosaccharides and mannanoligosaccharides influence immune function, ileal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs. Journal of Nutrition, 132, 980–989.
19. Tokunaga T, Nakada Y, Tashiro Y, Hirayama M and Hidaka H, 1993. Effects of fructooligosaccharides intake on the intestinal microflora and defecation in healthy volunteers. Bifidus, 6, 143–150.
20. Venema K, Vermunt SHF and Brink EJ, 2005. D-Tagatose increases butyrate production by the colonic microbiota in healthy men and women. Microbial Ecology in Health and Disease, 17, 47–57.
21. Xu ZR, Hu CH, Xia MS, Zhan XA and Wang MQ, 2003. Effects of dietary fructooligosaccharide on digestive enzyme activities, intestinal microflora and morphology of male broilers. Poultry Science, 82, 1030.